Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Arca Biopharma Inc (NQ: ABIO ) 3.260 +0.010 (+0.31%) Streaming Delayed Price Updated: 4:00 PM EDT, May 2, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Price and Volume Detailed Quote Volume 66,037 Open 3.350 Bid (Size) 3.200 (3) Ask (Size) 3.400 (5) Prev. Close 3.250 Today's Range 3.200 - 3.350 52wk Range 1.560 - 3.880 Shares Outstanding 14,410,143 Dividend Yield N/A Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year Top News More News ABIO Stock Earnings: ARCA biopharma Reported Results for Q1 2024 April 25, 2024 ARCA biopharma just reported results for the first quarter of 2024. Via InvestorPlace BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Shockwave Medical, Inc. (Nasdaq – SWAV), Apartment Income REIT Corp. (NYSE - AIRC), Model N, Inc. (NYSE – MODN), ARCA biopharma, Inc. (Nasdaq - ABIO) April 15, 2024 From Brodsky & Smith LLC Via GlobeNewswire Performance YTD +94.28% +94.28% 1 Month +90.64% +90.64% 3 Month +106.36% +106.36% 6 Month +81.11% +81.11% 1 Year +55.24% +55.24% More News Read More BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Shockwave Medical, Inc. (Nasdaq – SWAV), Apartment Income REIT Corp. (NYSE - AIRC), Model N, Inc. (NYSE – MODN), ARCA biopharma, Inc. (Nasdaq - ABIO) April 08, 2024 From Brodsky & Smith LLC Via GlobeNewswire Why Is ARCA Biopharma (ABIO) Stock Up 85% Today? April 03, 2024 Via InvestorPlace ARCA BIOPHARMA INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of ARCA biopharma, Inc. - ABIO April 05, 2024 From Kahn Swick & Foti, LLC Via Business Wire Why STAAR Surgical Shares Are Trading Higher By Around 13%? Here Are Other Stocks Moving In Thursday's Mid-Day Session April 04, 2024 Via Benzinga Why Flora Growth Shares Are Trading Lower By Around 20%; Here Are 20 Stocks Moving Premarket April 04, 2024 Via Benzinga Nasdaq Gains 75 Points; Acuity Brands Posts Upbeat Earnings April 03, 2024 Via Benzinga Topics Stocks Exposures US Equities 12 Health Care Stocks Moving In Wednesday's Intraday Session April 03, 2024 Via Benzinga Crude Oil Moves Higher; ISM Services PMI Falls In March April 03, 2024 Via Benzinga Topics Stocks Exposures Fossil Fuels US Equities Why Ulta Beauty Shares Are Trading Lower By Around 14%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session April 03, 2024 Via Benzinga Exposures Glyphosate ARCA Biopharma Inc. (NASDAQ: ABIO) is One of Wednesday Morning’s Most Active Stocks April 03, 2024 Via Investor Brand Network Small-Cap ARCA Biopharma Stock Soars On Merger Pact: The Details April 03, 2024 Via Benzinga US Stocks Edge Lower; Private Employment Tops Views April 03, 2024 Via Benzinga Topics Stocks Exposures US Equities ABIO Stock Alert: Halper Sadeh LLC Is Investigating Whether the Merger of ARCA Biopharma, Inc. Is Fair to Shareholders April 03, 2024 From Halper Sadeh LLC Via Business Wire 12 Health Care Stocks Moving In Wednesday's Pre-Market Session April 03, 2024 Via Benzinga ARCA biopharma and Oruka Therapeutics Announce Merger Agreement April 03, 2024 From Oruka Therapeutics, Inc. Via GlobeNewswire 12 Health Care Stocks Moving In Friday's After-Market Session June 17, 2022 Via Benzinga 12 Health Care Stocks Moving In Monday's After-Market Session April 18, 2022 Via Benzinga Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday April 04, 2022 Via InvestorPlace 26 Stocks Moving in Monday's Pre-Market Session April 04, 2022 Via Benzinga 38 Stocks Moving In Friday's Mid-Day Session April 01, 2022 Via Benzinga Mid-Morning Market Update: Markets Higher; US Economy Adds 431,000 Jobs In March April 01, 2022 Via Benzinga 12 Health Care Stocks Moving In Friday's Pre-Market Session April 01, 2022 Via Benzinga The Daily Biotech Pulse: SELLA In-licenses Oncology Asset, Merck's Pneumococcal Vaccine Review Extended, Arc Biopharma COVID Drug Flunks Mid-Stage Study April 01, 2022 Via Benzinga Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.